study,id,t,r,n,study_year,unpublished_data,rob,unpublished
CL3-20098-022,1,agomelatine,68,133,2001,1,2,0
CL3-20098-022,1,placebo,69,149,2001,1,2,0
CL3-20098-022-1,1_1,fluoxetine,77,137,2001,1,2,0
CL3-20098-022-1,1_1,placebo,69,149,2001,1,2,0
CL3-20098-023,2,agomelatine,71,142,2001,1,1,0
CL3-20098-023,2,placebo,63,137,2001,1,1,0
CL3-20098-023-1,2_1,paroxetine,74,138,2001,1,1,0
CL3-20098-023-1,2_1,placebo,63,137,2001,1,1,0
Kennedy2006 (CL3-20098-043),3,agomelatine,52,107,2003,1,1,0
Kennedy2006 (CL3-20098-043),3,placebo,36,105,2003,1,1,0
Olie2007 (CL3-20098-042),4,agomelatine,63,118,2004,1,1,0
Olie2007 (CL3-20098-042),4,placebo,42,120,2004,1,1,0
Stahl2010 (CAGO178A2302),5,agomelatine,141,337,2008,1,2,0
Stahl2010 (CAGO178A2302),5,placebo,54,166,2008,1,2,0
Zajecka2010 (CAGO178A2301) (NCT00411099),6,agomelatine,146,338,2008,1,1,0
Zajecka2010 (CAGO178A2301) (NCT00411099),6,placebo,63,173,2008,1,1,0
CL3-20098-024,7,agomelatine,175,301,2002,1,1,0
CL3-20098-024,7,placebo,91,158,2002,1,1,0
CL3-20098-024-1,7_1,fluoxetine,89,148,2002,1,1,0
CL3-20098-024-1,7_1,placebo,91,158,2002,1,1,0
CL3-20098-026,9,agomelatine,51,109,2001,1,1,0
CL3-20098-026,9,placebo,50,109,2001,1,1,0
CL3-20098-070,17,agomelatine,88,151,2011,1,1,0
CL3-20098-070,17,placebo,27,71,2011,1,1,0
CAGO178A2303 (NCT00463242),19,agomelatine,70,169,2008,1,2,1
CAGO178A2303 (NCT00463242),19,placebo,61,166,2008,1,2,1
CAGO178A2303 (NCT00463242)-1,19_1,paroxetine,91,168,2008,1,2,1
CAGO178A2303 (NCT00463242)-1,19_1,placebo,61,166,2008,1,2,1
Loo2002 (CL2-014),20,agomelatine,83,137,2002,1,2,0
Loo2002 (CL2-014),20,placebo,63,139,2002,1,2,0
Loo2002 (CL2-014)-1,20_1,paroxetine,81,147,2002,1,2,0
Loo2002 (CL2-014)-1,20_1,placebo,63,139,2002,1,2,0
"Kennedy2014 (EudraCT 2009-011238-84, CL3-20098-069)",21,agomelatine,141,275,2009,1,1,0
"Kennedy2014 (EudraCT 2009-011238-84, CL3-20098-069)",21,placebo,35,141,2009,1,1,0
Heun2013 (lSRCTl\l5750736O),22,agomelatine,88,151,2009,0,1,0
Heun2013 (lSRCTl\l5750736O),22,placebo,27,71,2009,0,1,0
Feighner1979,23,amitriptyline,41,93,1979,0,1,0
Feighner1979,23,placebo,16,50,1979,0,1,0
Shipley1981,27,amitriptyline,43,53,1981,0,2,0
Shipley1981,27,placebo,6,23,1981,0,2,0
Claghorn1983,30,amitriptyline,49,85,1983,0,1,0
Claghorn1983,30,placebo,36,87,1983,0,1,0
Hormazabal1985,32,amitriptyline,13,20,1985,0,1,0
Hormazabal1985,32,placebo,6,20,1985,0,1,0
Rickels1985,34,amitriptyline,85,124,1985,0,2,0
Rickels1985,34,placebo,44,130,1985,0,2,0
Amsterdam1986,35,amitriptyline,31,55,1986,0,2,0
Amsterdam1986,35,placebo,15,54,1986,0,2,0
Hicks1988,36,amitriptyline,11,16,1988,0,2,0
Hicks1988,36,placebo,5,15,1988,0,2,0
Paykel1988,37,amitriptyline,28,45,1988,0,2,0
Paykel1988,37,placebo,23,55,1988,0,2,0
Gelenberg1990,38,amitriptyline,6,19,1990,0,2,0
Gelenberg1990,38,placebo,6,22,1990,0,2,0
Bakish1992,41,amitriptyline,34,58,1992,0,2,0
Bakish1992,41,placebo,20,56,1992,0,2,0
Katz1993a,42,amitriptyline,51,95,1993,0,2,0
Katz1993a,42,placebo,30,94,1993,0,2,0
Kusalic1993,44,amitriptyline,10,13,1993,0,2,0
Kusalic1993,44,placebo,6,15,1993,0,2,0
Wilcox1994,45,amitriptyline,22,50,1994,0,2,0
Wilcox1994,45,placebo,10,49,1994,0,2,0
Mynors-Wallis1995,46,amitriptyline,12,31,1995,0,2,0
Mynors-Wallis1995,46,placebo,5,30,1995,0,2,0
Kane1983,48,bupropion,4,13,1983,0,1,0
Kane1983,48,placebo,2,7,1983,0,1,0
Feighner1984,49,bupropion,27,45,1984,0,2,0
Feighner1984,49,placebo,2,22,1984,0,2,0
Lineberry1990 (WELL 84A),50,bupropion,56,112,1988,1,2,0
Lineberry1990 (WELL 84A),50,placebo,36,112,1988,1,2,0
"Reimherr1998 (WELL203, FDA203)",53,placebo,41,121,1991,1,2,0
"Reimherr1998 (WELL203, FDA203)",53,bupropion,52,120,1991,1,2,0
Coleman1999 (AK1A4002),55,sertraline,67,118,1998,1,2,0
Coleman1999 (AK1A4002),55,placebo,66,124,1998,1,2,0
Croft1999 (AK1A4001),56,sertraline,79,119,1998,1,1,0
Croft1999 (AK1A4001),56,placebo,50,121,1998,1,1,0
Coleman2001 (AK1A4007),57,fluoxetine,83,154,2000,1,2,0
Coleman2001 (AK1A4007),57,placebo,73,152,2000,1,2,0
Coleman2001 (AK1A4007)-1,57_1,bupropion,76,150,2000,1,2,0
Coleman2001 (AK1A4007)-1,57_1,placebo,73,152,2000,1,2,0
Clayton2006b (WELL AK130927),61,escitalopram,90,138,2004,1,2,0
Clayton2006b (WELL AK130927),61,placebo,69,141,2004,1,2,0
Clayton2006b (WELL AK130927)-1,61_1,bupropion,82,141,2004,1,2,0
Clayton2006b (WELL AK130927)-1,61_1,placebo,69,141,2004,1,2,0
Clayton2006a (WELL AK130926),62,bupropion,81,138,2004,1,2,0
Clayton2006a (WELL AK130926),62,placebo,64,137,2004,1,2,0
Clayton2006a (WELL AK130926)-1,62_1,escitalopram,82,149,2004,1,2,0
Clayton2006a (WELL AK130926)-1,62_1,placebo,64,137,2004,1,2,0
Jefferson2006,63,placebo,52,139,2006,0,2,0
Jefferson2006,63,bupropion,70,135,2006,0,2,0
Hewett2009 (WXL101497),64,venlafaxine,120,189,2005,1,1,0
Hewett2009 (WXL101497),64,placebo,91,199,2005,1,1,0
Hewett2010a (AK130940) (NCT00093288),65,placebo,87,208,2005,1,2,0
Hewett2010a (AK130940) (NCT00093288),65,bupropion,109,212,2005,1,2,0
Hewett2010b (AK130939),66,venlafaxine,127,198,2005,1,2,0
Hewett2010b (AK130939),66,placebo,91,189,2005,1,2,0
Wellbutrin 06,67,bupropion,22,56,1978,1,1,1
Wellbutrin 06,67,placebo,7,29,1978,1,1,1
GSK14,68,bupropion,27,77,1979,1,2,1
GSK14,68,placebo,6,40,1979,1,2,1
845,69,bupropion,26,56,1980,1,2,1
845,69,placebo,17,52,1980,1,2,1
WELL 029,70,bupropion,8,25,1984,1,2,1
WELL 029,70,placebo,7,24,1984,1,2,1
Wellbutrin 25,71,bupropion,38,85,1985,1,2,1
Wellbutrin 25,71,placebo,14,43,1985,1,2,1
Study 205 (FDA) (WELL 205),72,bupropion,90,239,1993,1,2,1
Study 205 (FDA) (WELL 205),72,placebo,38,124,1993,1,2,1
WELL AK1A4006,73,fluoxetine,88,155,2000,1,2,1
WELL AK1A4006,73,placebo,78,154,2000,1,2,1
WELL AK1A4006-1,73_1,bupropion,74,158,2000,1,2,1
WELL AK1A4006-1,73_1,placebo,78,154,2000,1,2,1
Koshino2013 (NCT01138007),76,bupropion,82,192,2012,1,1,0
Koshino2013 (NCT01138007),76,placebo,86,187,2012,1,1,0
Study 89306 (FDA),78,citalopram,98,185,1998,1,2,1
Study 89306 (FDA),78,placebo,42,89,1998,1,2,1
Montgomery1992 (Study 89303 FDA),79,citalopram,67,134,1992,1,2,1
Montgomery1992 (Study 89303 FDA),79,placebo,28,66,1992,1,2,1
Feighner1999 (Study 91206 FDA),80,citalopram,141,261,1999,1,2,0
Feighner1999 (Study 91206 FDA),80,placebo,42,129,1999,1,2,0
Stahl2000,88,sertraline,55,108,2000,0,2,0
Stahl2000,88,placebo,43,108,2000,0,2,0
Roose2004 (CIT-MD-03),89,citalopram,34,87,2001,1,2,0
Roose2004 (CIT-MD-03),89,placebo,34,91,2001,1,2,0
Gastpar2006,93,citalopram,71,127,2006,0,1,0
Gastpar2006,93,placebo,51,130,2006,0,1,0
"Liebowitz2008 (Study 332, NCT00277823)",95,desvenlafaxine,155,299,2008,1,1,0
"Liebowitz2008 (Study 332, NCT00277823)",95,placebo,66,152,2008,1,1,0
"Boyer2008 (Study 333, NCT00300378)(EUCTR2005-005463-28, 3151A1-333-EU)",96,desvenlafaxine,207,324,2004,1,1,0
"Boyer2008 (Study 333, NCT00300378)(EUCTR2005-005463-28, 3151A1-333-EU)",96,placebo,80,161,2004,1,1,0
"Lieberman2008a (Study 309)(EUCTR2004-000562-13, 3151A1-309-EU, NCT00090649)",97,placebo,60,120,2004,1,1,0
"Lieberman2008a (Study 309)(EUCTR2004-000562-13, 3151A1-309-EU, NCT00090649)",97,venlafaxine,81,127,2004,1,1,0
Lieberman2008b (Study 317),98,placebo,55,125,2004,1,1,0
Lieberman2008b (Study 317),98,venlafaxine,66,117,2004,1,1,0
Tourian2009 (NCT00384033),99,desvenlafaxine,132,315,2009,1,2,0
Tourian2009 (NCT00384033),99,placebo,61,164,2009,1,2,0
Tourian2009 (NCT00384033)-1,99_1,duloxetine,74,159,2009,1,2,0
Tourian2009 (NCT00384033)-1,99_1,placebo,61,164,2009,1,2,0
Dunlop2011 (NCT00824291),100,desvenlafaxine,174,291,2011,0,2,0
Dunlop2011 (NCT00824291),100,placebo,65,146,2011,0,2,0
Clayton2013 (NCT01121484),101,desvenlafaxine,89,218,2013,0,1,0
Clayton2013 (NCT01121484),101,placebo,72,221,2013,0,1,0
Iwata2013 (NCT00798707),102,desvenlafaxine,109,237,2013,0,1,0
Iwata2013 (NCT00798707),102,placebo,81,235,2013,0,1,0
Liebowitz2013 (NCT00863798),103,desvenlafaxine,92,227,2013,0,1,0
Liebowitz2013 (NCT00863798),103,placebo,85,227,2013,0,1,0
Clayton2015,104,placebo,116,306,2015,1,1,0
Clayton2015,104,desvenlafaxine,274,618,2015,1,1,0
"DeMartinis2007 (Study 306, NCT00072774)",105,placebo,34,120,2004,1,2,0
"DeMartinis2007 (Study 306, NCT00072774)",105,desvenlafaxine,50,118,2004,1,2,0
Goldstein2002 (HMAQ - Study Group A),106,duloxetine,33,70,2000,1,2,0
Goldstein2002 (HMAQ - Study Group A),106,placebo,24,70,2000,1,2,0
Goldstein2002 (HMAQ - Study Group A)-1,106_1,fluoxetine,15,33,2000,1,2,0
Goldstein2002 (HMAQ - Study Group A)-1,106_1,placebo,24,70,2000,1,2,0
Study F1J-MC-HMAQ - Study Group B (starting page in the pdf document: 147),107,duloxetine,40,82,2001,1,2,1
Study F1J-MC-HMAQ - Study Group B (starting page in the pdf document: 147),107,placebo,28,75,2001,1,2,1
Study F1J-MC-HMAQ - Study Group B (starting page in the pdf document: 147)-1,107_1,fluoxetine,15,37,2001,1,2,1
Study F1J-MC-HMAQ - Study Group B (starting page in the pdf document: 147)-1,107_1,placebo,28,75,2001,1,2,1
"Goldstein2004a (HMAT - Study Group A, ID#4091)",108,duloxetine,52,175,2001,1,2,0
"Goldstein2004a (HMAT - Study Group A, ID#4091)",108,placebo,24,90,2001,1,2,0
"Goldstein2004a (HMAT - Study Group A, ID#4091)-1",108_1,paroxetine,38,89,2001,1,2,0
"Goldstein2004a (HMAT - Study Group A, ID#4091)-1",108_1,placebo,24,90,2001,1,2,0
"Goldstein2004b (HMAT  - Study Group B, ID#4091)",109,duloxetine,81,177,2001,1,2,0
"Goldstein2004b (HMAT  - Study Group B, ID#4091)",109,placebo,27,89,2001,1,2,0
"Goldstein2004b (HMAT  - Study Group B, ID#4091)-1",109_1,paroxetine,34,87,2001,1,2,0
"Goldstein2004b (HMAT  - Study Group B, ID#4091)-1",109_1,placebo,27,89,2001,1,2,0
Detke2002a (HMBH -  Study Group A),110,duloxetine,55,123,2002,1,2,0
Detke2002a (HMBH -  Study Group A),110,placebo,27,122,2002,1,2,0
Detke2002b (HMBH - Study Group B),111,duloxetine,62,128,2002,1,2,0
Detke2002b (HMBH - Study Group B),111,placebo,48,139,2002,1,2,0
Detke2004 (HMAY Study Group A),112,duloxetine,126,188,2004,1,1,0
Detke2004 (HMAY Study Group A),112,placebo,41,93,2004,1,1,0
Detke2004 (HMAY Study Group A)-1,112_1,paroxetine,63,86,2004,1,1,0
Detke2004 (HMAY Study Group A)-1,112_1,placebo,41,93,2004,1,1,0
Raskin2007 (HMBV) (NCT00062673),114,duloxetine,75,207,2004,1,2,0
Raskin2007 (HMBV) (NCT00062673),114,placebo,19,104,2004,1,2,0
"Nierenberg2007 (F1J-MC-HMCR, NCT00073411, Pigott2007)",116,escitalopram,121,274,2005,1,1,0
"Nierenberg2007 (F1J-MC-HMCR, NCT00073411, Pigott2007)",116,placebo,50,137,2005,1,1,0
"Nierenberg2007 (F1J-MC-HMCR, NCT00073411, Pigott2007)-1",116_1,duloxetine,128,273,2005,1,1,0
"Nierenberg2007 (F1J-MC-HMCR, NCT00073411, Pigott2007)-1",116_1,placebo,50,137,2005,1,1,0
Perahia2006 (HMAY - Study Group B),118,duloxetine,129,196,2006,1,2,0
Perahia2006 (HMAY - Study Group B),118,placebo,51,99,2006,1,1,0
Perahia2006 (HMAY - Study Group B)-1,118_1,paroxetine,59,97,2006,1,1,0
Perahia2006 (HMAY - Study Group B)-1,118_1,placebo,51,99,2006,1,1,0
Higuchi2009,119,duloxetine,80,150,2009,0,1,0
Higuchi2009,119,placebo,56,146,2009,0,1,0
Higuchi2009-1,119_1,paroxetine,78,148,2009,0,1,0
Higuchi2009-1,119_1,placebo,56,146,2009,0,1,0
Cutler2009,120,duloxetine,70,151,2009,0,1,0
Cutler2009,120,placebo,55,157,2009,0,1,0
Oakes2012a (NCT00536471),122,duloxetine,113,257,2008,1,1,0
Oakes2012a (NCT00536471),122,placebo,45,127,2008,1,1,0
Oakes2012b (NCT00536471),123,duloxetine,117,261,2008,1,1,0
Oakes2012b (NCT00536471),123,placebo,44,131,2008,1,1,0
Burke2002 (SCT-MD-01),126,escitalopram,102,252,2000,1,2,0
Burke2002 (SCT-MD-01),126,placebo,32,127,2000,1,2,0
Burke2002 (SCT-MD-01)-1,126_1,citalopram,48,127,2000,1,2,0
Burke2002 (SCT-MD-01)-1,126_1,placebo,32,127,2000,1,2,0
Gorman2002 (SCT-MD-02),127,escitalopram,51,129,2000,1,2,0
Gorman2002 (SCT-MD-02),127,placebo,47,129,2000,1,2,0
Gorman2002 (SCT-MD-02)-1,127_1,citalopram,54,128,2000,1,2,0
Gorman2002 (SCT-MD-02)-1,127_1,placebo,47,129,2000,1,2,0
Lepola2003 (ESC 99003),128,escitalopram,95,156,2000,1,1,0
Lepola2003 (ESC 99003),128,placebo,67,154,2000,1,1,0
Lepola2003 (ESC 99003)-1,128_1,citalopram,79,161,2000,1,1,0
Lepola2003 (ESC 99003)-1,128_1,placebo,67,154,2000,1,1,0
Ninan2003 (poster SCT-MD-26),131,escitalopram,61,154,2002,1,2,1
Ninan2003 (poster SCT-MD-26),131,placebo,48,155,2002,1,2,1
Wade2002 (ESC Study 99001 - FDA),134,placebo,79,189,2002,1,1,0
Wade2002 (ESC Study 99001 - FDA),134,escitalopram,104,191,2002,1,1,0
Bose2008 (SCT-MD-13),137,escitalopram,50,132,2004,1,2,1
Bose2008 (SCT-MD-13),137,placebo,50,135,2004,1,2,1
Alexopoulos2004 (poster SCT-MD-27),138,escitalopram,68,136,2004,1,2,0
Alexopoulos2004 (poster SCT-MD-27),138,placebo,54,135,2004,1,2,0
Alexopoulos2004 (poster SCT-MD-27)-1,138_1,sertraline,74,138,2004,1,2,0
Alexopoulos2004 (poster SCT-MD-27)-1,138_1,placebo,54,135,2004,1,2,0
Kasper2005a (Study 99024),141,escitalopram,78,174,2005,1,2,0
Kasper2005a (Study 99024),141,placebo,85,180,2005,1,2,0
Kasper2005a (Study 99024)-1,141_1,fluoxetine,61,164,2005,1,2,0
Kasper2005a (Study 99024)-1,141_1,placebo,85,180,2005,1,2,0
Hirayasu2011a,153,escitalopram,133,205,2011,0,1,0
Hirayasu2011a,153,placebo,66,105,2011,0,1,0
Hirayasu2011b,154,placebo,45,124,2011,0,1,0
Hirayasu2011b,154,escitalopram,115,240,2011,0,1,0
Hirayasu2011b-1,154_1,placebo,45,124,2011,0,1,0
Hirayasu2011b-1,154_1,paroxetine,64,121,2011,0,1,0
Dube2010 (NCT00420004),155,escitalopram,29,62,2008,0,2,0
Dube2010 (NCT00420004),155,placebo,59,138,2008,0,2,0
Kasper2012 (NCT00807248),157,escitalopram,97,140,2008,0,2,0
Kasper2012 (NCT00807248),157,placebo,33,71,2008,0,2,0
"Wang 2014 (EUCTR2005-005052-40, NCT00351169, D1448C00004)",158,escitalopram,91,157,2007,0,1,0
"Wang 2014 (EUCTR2005-005052-40, NCT00351169, D1448C00004)",158,placebo,78,157,2007,0,1,0
Griebel2012 (Study DF15878) (NCT00358631),160,escitalopram,30,84,2007,0,2,0
Griebel2012 (Study DF15878) (NCT00358631),160,placebo,22,76,2007,0,2,0
NCT01020799,161,escitalopram,14,50,2009,1,1,1
NCT01020799,161,placebo,31,99,2009,1,1,1
SCT-MD-49 (NCT00668525),162,escitalopram,116,325,2009,1,2,1
SCT-MD-49 (NCT00668525),162,placebo,54,220,2009,1,1,1
Mischoulon2014 (NCT00101452),163,escitalopram,22,69,2009,1,2,0
Mischoulon2014 (NCT00101452),163,placebo,18,65,2009,1,2,0
Study 19 (FDA) (Fabre1985),164,fluoxetine,6,22,1985,1,2,1
Study 19 (FDA) (Fabre1985),164,placebo,3,25,1985,1,2,1
Study 25 (FDA) (Rickels1986),165,fluoxetine,5,18,1986,1,2,1
Study 25 (FDA) (Rickels1986),165,placebo,7,24,1986,1,2,1
Study 62a (FDA) - MILD depression (Dunlop1990),166,fluoxetine,114,316,1990,1,2,1
Study 62a (FDA) - MILD depression (Dunlop1990),166,placebo,21,56,1990,1,2,1
Study 62b (FDA) - MODERATE depression,167,fluoxetine,104,308,1987,1,2,1
Study 62b (FDA) - MODERATE depression,167,placebo,11,48,1987,1,2,1
Cohn1985a,169,fluoxetine,38,54,1985,0,2,0
Cohn1985a,169,placebo,12,58,1985,0,2,0
Stark1985 (Study 27 - FDA),171,fluoxetine,73,185,1985,1,2,0
Stark1985 (Study 27 - FDA),171,placebo,44,169,1985,1,2,0
Byerley1988,173,placebo,4,29,1988,0,1,0
Byerley1988,173,fluoxetine,14,32,1988,0,1,0
Feighner1989a,178,placebo,9,59,1989,0,2,0
Feighner1989a,178,fluoxetine,15,62,1989,0,2,0
Heiligenstein1994,191,fluoxetine,25,46,1994,0,1,0
Heiligenstein1994,191,placebo,17,43,1994,0,1,0
Lam1995,192,fluoxetine,23,36,1995,0,2,0
Lam1995,192,placebo,13,32,1995,0,2,0
Tollefson1995,193,fluoxetine,125,335,1995,0,2,0
Tollefson1995,193,placebo,91,336,1995,0,2,0
Sramek1995,194,fluoxetine,14,72,1995,0,1,0
Sramek1995,194,placebo,10,72,1995,0,1,0
Corrigan2000  ,199,fluoxetine,17,35,2000,0,2,0
Corrigan2000  ,199,placebo,9,35,2000,0,2,0
McGrath2000,200,fluoxetine,25,49,2000,0,2,0
McGrath2000,200,placebo,12,52,2000,0,2,0
LopezRodriguez2004,202,fluoxetine,6,10,2004,0,2,0
LopezRodriguez2004,202,placebo,3,10,2004,0,2,0
NCT01808612,205,fluoxetine,55,253,2013,1,1,1
NCT01808612,205,placebo,72,260,2013,1,1,1
Fava2005,206,placebo,15,43,2005,0,2,0
Fava2005,206,fluoxetine,15,47,2005,0,2,0
Bjerkenstedt2005  ,207,fluoxetine,20,57,2005,0,1,0
Bjerkenstedt2005  ,207,placebo,23,58,2005,0,1,0
Moreno2005,208,fluoxetine,11,20,2005,0,2,0
Moreno2005,208,placebo,11,26,2005,0,2,0
Amin1984,211,fluvoxamine,77,161,1984,0,2,0
Amin1984,211,placebo,44,150,1984,0,2,0
Norton1984,212,fluvoxamine,13,35,1984,0,1,0
Norton1984,212,placebo,10,25,1984,0,1,0
Dominguez1985,213,fluvoxamine,8,35,1985,1,2,0
Dominguez1985,213,placebo,8,31,1985,1,2,0
Cassano1986,214,fluvoxamine,84,161,1986,0,2,0
Cassano1986,214,placebo,53,149,1986,0,2,0
Lapierre1987,216,fluvoxamine,14,22,1987,0,2,0
Lapierre1987,216,placebo,5,20,1987,0,2,0
Feighner1989b,217,fluvoxamine,13,31,1989,0,1,0
Feighner1989b,217,placebo,4,19,1989,0,1,0
Lydiard1989,218,fluvoxamine,9,18,1989,0,2,0
Lydiard1989,218,placebo,5,18,1989,0,2,0
Mar-90,219,fluvoxamine,7,18,1990,0,1,0
Mar-90,219,placebo,3,18,1990,0,1,0
Claghorn1996,224,fluvoxamine,21,50,1996,0,2,0
Claghorn1996,224,placebo,12,50,1996,0,2,0
Fabre1996,225,fluvoxamine,23,50,1996,0,1,0
Fabre1996,225,placebo,15,50,1996,0,1,0
Roth1990,231,fluvoxamine,17,30,1990,0,2,0
Roth1990,231,placebo,11,30,1990,0,2,0
"Montgomery2013 (F02695LP202, EudraCT2006-002404-34)",233,placebo,107,281,2007,1,1,0
"Montgomery2013 (F02695LP202, EudraCT2006-002404-34)",233,levomilnacipran,155,282,2007,1,1,0
"Gommoll2014 (LVM-MD-02, NCT00969150)",234,placebo,63,182,2010,1,1,0
"Gommoll2014 (LVM-MD-02, NCT00969150)",234,levomilnacipran,67,175,2010,1,1,0
"Asnis2013 (LVM-MD-01, NCT00969709)",235,placebo,51,179,2011,1,2,0
"Asnis2013 (LVM-MD-01, NCT00969709)",235,levomilnacipran,203,545,2011,1,2,0
"Sambunaris2014 (LVM-MD-03, NCT01034462)",236,placebo,63,220,2011,1,1,0
"Sambunaris2014 (LVM-MD-03, NCT01034462)",236,levomilnacipran,90,222,2011,1,1,0
"Bakish2014 (LVM-MD-10, NCT01377194)",237,placebo,57,189,2012,1,1,0
"Bakish2014 (LVM-MD-10, NCT01377194)",237,levomilnacipran,156,379,2012,1,1,0
MIR 003-003 (FDA),249,mirtazapine,18,45,1996,1,2,1
MIR 003-003 (FDA),249,placebo,14,45,1996,1,2,1
MIR 003-020 (FDA),250,mirtazapine,17,44,1996,1,2,1
MIR 003-020 (FDA),250,placebo,5,43,1996,1,2,1
MIR 003-020 (FDA)-1,250_1,amitriptyline,14,43,1996,1,2,1
MIR 003-020 (FDA)-1,250_1,placebo,5,43,1996,1,2,1
MIR 003-021 (FDA),251,mirtazapine,22,50,1996,1,2,1
MIR 003-021 (FDA),251,placebo,21,50,1996,1,2,1
MIR 003-021 (FDA)-1,251_1,amitriptyline,31,50,1996,1,2,1
MIR 003-021 (FDA)-1,251_1,placebo,21,50,1996,1,2,1
Vartiainen1994 (MIR 84023 FDA),252,mirtazapine,19,60,1994,1,2,0
Vartiainen1994 (MIR 84023 FDA),252,placebo,15,57,1994,1,2,0
Smith1990 (MIR 003-024 FDA),254,mirtazapine,25,50,1990,1,2,0
Smith1990 (MIR 003-024 FDA),254,placebo,14,50,1990,1,2,0
Smith1990 (MIR 003-024 FDA)-1,254_1,amitriptyline,26,50,1990,1,2,0
Smith1990 (MIR 003-024 FDA)-1,254_1,placebo,14,50,1990,1,2,0
Bremner1995(MIR 003-022 - FDA),255,amitriptyline,29,50,1995,1,2,0
Bremner1995(MIR 003-022 - FDA),255,placebo,17,50,1995,1,2,0
Bremner1995(MIR 003-022 - FDA)-1,255_1,mirtazapine,34,50,1995,1,2,0
Bremner1995(MIR 003-022 - FDA)-1,255_1,placebo,17,50,1995,1,2,0
Claghorn1995 (MIR 003-002 (FDA),256,mirtazapine,21,45,1995,1,2,0
Claghorn1995 (MIR 003-002 (FDA),256,placebo,11,45,1995,1,2,0
Halikas1995 (MIR 003-023 - FDA),257,mirtazapine,25,50,1995,1,2,0
Halikas1995 (MIR 003-023 - FDA),257,placebo,17,50,1995,1,2,0
Halikas1995 (MIR 003-023 - FDA)-1,257_1,trazodone,20,50,1995,1,2,0
Halikas1995 (MIR 003-023 - FDA)-1,257_1,placebo,17,50,1995,1,2,0
Kinoshita2009,273,mirtazapine,131,211,2009,0,1,0
Kinoshita2009,273,placebo,37,70,2009,0,1,0
003-048,274,mirtazapine,78,210,2001,1,2,1
003-048,274,placebo,24,72,2001,1,2,1
003-048-1,274_1,fluoxetine,80,210,2001,1,2,1
003-048-1,274_1,placebo,24,72,2001,1,2,1
003-008 (FDA),275,mirtazapine,18,60,1990,1,2,1
003-008 (FDA),275,placebo,7,30,1990,1,2,1
003-042,276,mirtazapine,85,210,1998,1,2,1
003-042,276,placebo,19,70,1998,1,2,1
D'Amico1990 (FDA 030-A2-0007),288,nefazodone,16,47,1990,1,2,0
D'Amico1990 (FDA 030-A2-0007),288,placebo,16,47,1990,1,2,0
Feighner1998,290,nefazodone,29,61,1998,0,2,0
Feighner1998,290,placebo,17,59,1998,0,2,0
Fontaine1994 (FDA 03A0A-003),291,nefazodone,25,44,1994,1,2,0
Fontaine1994 (FDA 03A0A-003),291,placebo,14,45,1994,1,2,0
Mendels1995 (FDA 03A0A-004B),294,nefazodone,45,80,1995,1,2,0
Mendels1995 (FDA 03A0A-004B),294,placebo,29,80,1995,1,2,0
Rickels1994 ( FDA CN104-005),295,nefazodone,42,96,1994,1,2,0
Rickels1994 ( FDA CN104-005),295,placebo,29,95,1994,1,2,0
Rickels1995 (FDA CN104-006-1),296,nefazodone,26,45,1995,1,2,0
Rickels1995 (FDA CN104-006-1),296,placebo,23,44,1995,1,2,0
Cohn1996 (FDA CN104-006-2),297,nefazodone,25,43,1996,1,2,0
Cohn1996 (FDA CN104-006-2),297,placebo,15,43,1996,1,2,0
03A0A-004A (FDA),300,nefazodone,29,80,1994,1,2,1
03A0A-004A (FDA),300,placebo,28,80,1994,1,2,1
PAR 01 001 (GSK & FDA),309,paroxetine,11,25,1985,1,2,0
PAR 01 001 (GSK & FDA),309,placebo,8,25,1985,1,2,0
PAR 279 MDUK,313,paroxetine,12,19,1986,1,2,1
PAR 279 MDUK,313,placebo,5,10,1986,1,2,1
"Dunbar1993a (Claghorn1992, Rickels1989, Rickels1992, PAR 02-001 - FDA)",314,paroxetine,27,55,1986,1,2,0
"Dunbar1993a (Claghorn1992, Rickels1989, Rickels1992, PAR 02-001 - FDA)",314,placebo,16,56,1986,1,2,0
"Dunbar1993b  (Claghorn1992, PAR 02-002 - FDA)",315,paroxetine,15,36,1986,1,2,0
"Dunbar1993b  (Claghorn1992, PAR 02-002 - FDA)",315,placebo,8,36,1986,1,2,0
"Dunbar1993c  (Smith1992, PAR 02-003 - FDA)",316,paroxetine,13,39,1986,1,2,0
"Dunbar1993c  (Smith1992, PAR 02-003 - FDA)",316,placebo,10,38,1986,1,2,0
Feighner1993a (Feighner 1989c PAR 03 001 - FDA),317,paroxetine,20,40,1986,1,2,0
Feighner1993a (Feighner 1989c PAR 03 001 - FDA),317,placebo,5,40,1986,1,2,0
Feighner1993b (Cohn1990 Cohn1992 PAR 03 002 - FDA),318,paroxetine,9,40,1986,1,2,0
Feighner1993b (Cohn1990 Cohn1992 PAR 03 002 - FDA),318,placebo,6,40,1986,1,2,0
Feighner1993c (PAR 03 003 - FDA),319,paroxetine,17,41,1986,1,2,0
Feighner1993c (PAR 03 003 - FDA),319,placebo,14,42,1986,1,2,0
Feighner1993d (Shrivastava1992 PAR 03 004 - FDA),320,paroxetine,16,40,1986,1,2,0
Feighner1993d (Shrivastava1992 PAR 03 004 - FDA),320,placebo,9,40,1986,1,2,0
Feighner1993e (Peselow1989 PAR 03 005 - FDA),321,paroxetine,16,40,1986,1,2,0
Feighner1993e (Peselow1989 PAR 03 005 - FDA),321,placebo,12,42,1986,1,2,0
Feighner1993f (Fabre1992 PAR 03 006 - FDA),322,paroxetine,12,40,1986,1,2,0
Feighner1993f (Fabre1992 PAR 03 006 - FDA),322,placebo,3,40,1986,1,2,0
29060 07 001,323,paroxetine,5,13,1987,1,2,1
29060 07 001,323,placebo,4,12,1987,1,2,1
"Dunbar1993d (Kiev1992, PAR 02-004 - FDA)",325,paroxetine,15,40,1987,1,2,0
"Dunbar1993d (Kiev1992, PAR 02-004 - FDA)",325,placebo,7,41,1987,1,2,0
Miller1989 (MDUK/29060/III/82/006 (PAR-274) PAR UK 06 - FDA),328,paroxetine,3,22,1988,1,2,0
Miller1989 (MDUK/29060/III/82/006 (PAR-274) PAR UK 06 - FDA),328,placebo,5,25,1988,1,2,0
MY-1045/BRL-029060/1 (PAR 128),333,paroxetine,217,357,1991,1,2,1
MY-1045/BRL-029060/1 (PAR 128),333,placebo,69,140,1991,1,2,1
MY-1045/BRL-029060/1 (PAR 128)-1,333_1,fluoxetine,244,351,1991,1,2,1
MY-1045/BRL-029060/1 (PAR 128)-1,333_1,placebo,69,140,1991,1,2,1
MY-1043/BRL-029060/115,334,paroxetine,152,284,1991,1,2,1
MY-1043/BRL-029060/115,334,placebo,60,118,1991,1,2,1
MY-1043/BRL-029060/115-1,334_1,fluoxetine,167,289,1991,1,2,1
MY-1043/BRL-029060/115-1,334_1,placebo,60,118,1991,1,2,1
Dunner1992 (PAR 29060.09),341,paroxetine,135,316,1992,1,2,0
Dunner1992 (PAR 29060.09),341,placebo,20,53,1992,1,2,0
MY-1042/BRL-029060/CPMS-251,345,paroxetine,56,125,1993,1,2,1
MY-1042/BRL-029060/CPMS-251,345,placebo,44,129,1993,1,2,1
Edwards1989 (MD/PAR/009 PAR-276),346,paroxetine,7,21,1989,1,2,0
Edwards1989 (MD/PAR/009 PAR-276),346,placebo,3,21,1989,1,2,0
Golden2002a (29060/448),352,paroxetine,106,212,1997,1,2,0
Golden2002a (29060/448),352,placebo,42,103,1997,1,2,0
Golden2002b (29060/449),353,paroxetine,117,220,1997,1,2,0
Golden2002b (29060/449),353,placebo,47,110,1997,1,2,0
Rapaport2003 (PAR487),354,paroxetine,142,210,1997,1,2,0
Rapaport2003 (PAR487),354,placebo,56,109,1997,1,2,0
Fava1998,357,paroxetine,32,55,1998,0,2,0
Fava1998,357,placebo,10,19,1998,0,2,0
Fava1998-1,357_1,fluoxetine,31,54,1998,0,2,0
Fava1998-1,357_1,placebo,10,19,1998,0,2,0
Kramer1998,358,paroxetine,33.12,72,1998,0,2,0
Kramer1998,358,placebo,20,70,1998,0,2,0
Jefferson2000 (29060/785),362,placebo,36,105,2001,1,2,0
Jefferson2000 (29060/785),362,paroxetine,43,103,2001,1,2,0
Jefferson2000 (29060/785)-1,362_1,placebo,36,105,2001,1,2,0
Jefferson2000 (29060/785)-1,362_1,citalopram,102,207,2001,1,2,0
Trivedi2004 (29060/810),363,placebo,72,149,2002,1,2,0
Trivedi2004 (29060/810),363,paroxetine,91,154,2002,1,2,0
NKD20006 (NCT00048204),366,paroxetine,57,125,2003,1,2,1
NKD20006 (NCT00048204),366,placebo,59,125,2003,1,2,1
Rapaport2009 (BRL-29060/874) (NCT00067444),367,paroxetine,100,177,2004,1,2,0
Rapaport2009 (BRL-29060/874) (NCT00067444),367,placebo,71,180,2004,1,2,0
Katz2004,368,paroxetine,11,28,2004,0,1,0
Katz2004,368,placebo,6,25,2004,0,1,0
Dimidjian2006,369,paroxetine,25,100,2006,0,2,0
Dimidjian2006,369,placebo,12,53,2006,0,2,0
"Higuchi2011 (PCR112810, NCT00866294)",370,paroxetine,146,244,2010,1,1,0
"Higuchi2011 (PCR112810, NCT00866294)",370,placebo,78,172,2010,1,1,0
Learned2012b Study2 (NCT00420641),372,paroxetine,136,166,2012,0,2,0
Learned2012b Study2 (NCT00420641),372,placebo,97,156,2012,0,2,0
Keller2006c (Study062) (NCT00048607),377,paroxetine,105,164,2003,0,2,0
Keller2006c (Study062) (NCT00048607),377,placebo,76,161,2003,0,2,0
Griebel2012b (Study DF15879) (NCT00361491),378,paroxetine,54,80,2007,0,2,0
Griebel2012b (Study DF15879) (NCT00361491),378,placebo,40,79,2007,0,2,0
Versiani2000 (Study 091),380,reboxetine,20,28,1990,1,2,0
Versiani2000 (Study 091),380,placebo,5,28,1990,1,2,0
Study 015,382,reboxetine,65,112,1992,1,1,1
Study 015,382,placebo,58,112,1992,1,1,1
Bosc1997a (Study 014 - Andreoli2002),384,reboxetine,70,126,1997,1,2,0
Bosc1997a (Study 014 - Andreoli2002),384,placebo,43,128,1997,1,2,0
Bosc1997a (Study 014 - Andreoli2002)-1,384_1,fluoxetine,72,127,1997,1,2,0
Bosc1997a (Study 014 - Andreoli2002)-1,384_1,placebo,43,128,1997,1,2,0
Ban1998 (Study 008),385,reboxetine,50,84,1998,1,1,0
Ban1998 (Study 008),385,placebo,30,85,1998,1,1,0
Study 049,386,reboxetine,42,107,1998,1,2,1
Study 049,386,placebo,35,105,1998,1,2,1
Study 045,387,reboxetine,38,89,1999,1,2,1
Study 045,387,placebo,39,87,1999,1,2,1
Clayton2003 (Study 050),388,reboxetine,60,150,1999,1,2,0
Clayton2003 (Study 050),388,placebo,63,150,1999,1,2,0
Clayton2003 (Study 050)-1,388_1,fluoxetine,79,150,1999,1,2,0
Clayton2003 (Study 050)-1,388_1,placebo,63,150,1999,1,2,0
M/2020/0046 (Study 046),390,reboxetine,144,265,2000,1,2,1
M/2020/0046 (Study 046),390,placebo,136,257,2000,1,2,1
M/2020/0046 (Study 046)-1,390_1,paroxetine,156,265,2000,1,2,1
M/2020/0046 (Study 046)-1,390_1,placebo,136,257,2000,1,2,1
M/2020/0047 (Study 047),391,reboxetine,120,258,2000,1,2,1
M/2020/0047 (Study 047),391,placebo,108,254,2000,1,2,1
M/2020/0047 (Study 047)-1,391_1,paroxetine,128,262,2000,1,2,1
M/2020/0047 (Study 047)-1,391_1,placebo,108,254,2000,1,2,1
Studie009 (CTN009-FCE20124),394,reboxetine,14,26,1989,1,1,1
Studie009 (CTN009-FCE20124),394,placebo,9,24,1989,1,1,1
Reimherr1990 (SER 104 - FDA),396,amitriptyline,86,149,1990,1,2,0
Reimherr1990 (SER 104 - FDA),396,placebo,49,150,1990,1,2,0
Reimherr1990 (SER 104 - FDA)-1,396_1,sertraline,77,149,1990,1,2,0
Reimherr1990 (SER 104 - FDA)-1,396_1,placebo,49,150,1990,1,2,0
Doogan1994,401,sertraline,50,99,1994,0,1,0
Doogan1994,401,placebo,40,101,1994,0,1,0
Lydiard1997,404,amitriptyline,55,131,1997,0,2,0
Lydiard1997,404,placebo,43,129,1997,0,2,0
Lydiard1997-1,404_1,sertraline,60,132,1997,0,2,0
Lydiard1997-1,404_1,placebo,43,129,1997,0,2,0
Schneider2003,415,sertraline,126,371,2003,0,1,0
Schneider2003,415,placebo,96,376,2003,0,1,0
Moscovitch2004,416,sertraline,52,93,2004,0,1,0
Moscovitch2004,416,placebo,47,94,2004,0,1,0
Barber2011,417,sertraline,34,55,2007,0,2,0
Barber2011,417,placebo,35,50,2007,0,2,0
Binnemann2008 (NCT00143091),418,sertraline,25,43,2008,1,2,0
Binnemann2008 (NCT00143091),418,placebo,17,39,2008,1,2,0
Brunoni2012,419,sertraline,10,30,2012,0,1,0
Brunoni2012,419,placebo,5,30,2012,0,1,0
Fabre1995 (SER 103 FDA),421,sertraline,99,278,1991,1,2,0
Fabre1995 (SER 103 FDA),421,placebo,22,91,1991,1,2,0
SER 315 (FDA),423,sertraline,21,85,1991,1,2,1
SER 315 (FDA),423,placebo,25,80,1991,1,2,1
SER 315 (FDA)-1,423_1,amitriptyline,35,77,1991,1,2,1
SER 315 (FDA)-1,423_1,placebo,25,80,1991,1,2,1
Mao2015 (NCT01098318),424,sertraline,10,19,2013,0,2,0
Mao2015 (NCT01098318),424,placebo,7,18,2013,0,2,0
Mundt2012 (NCT00406952),425,sertraline,33,80,2007,0,2,0
Mundt2012 (NCT00406952),425,placebo,20,85,2007,0,2,0
Davidson2002 (HDTSG) (NCT00005013),426,sertraline,53,111,2002,0,1,0
Davidson2002 (HDTSG) (NCT00005013),426,placebo,50,116,2002,0,1,0
Olie1997,427,sertraline,70,129,1997,0,2,0
Olie1997,427,placebo,45,129,1997,0,2,0
Fabre1979,433,trazodone,5,13,1979,0,2,0
Fabre1979,433,placebo,1,11,1979,0,2,0
Feighner1980,435,trazodone,9,19,1980,0,2,0
Feighner1980,435,placebo,0,10,1980,0,2,0
Gerner1980,436,trazodone,2,19,1980,0,2,0
Gerner1980,436,placebo,7,20,1980,0,2,0
Sheehan2009b (NCT00775203),445,trazodone,109,206,2009,1,2,0
Sheehan2009b (NCT00775203),445,placebo,84,206,2009,1,2,0
Rickels1982,446,amitriptyline,36,68,1982,0,2,0
Rickels1982,446,placebo,18,68,1982,0,2,0
Rickels1982-1,446_1,trazodone,33,66,1982,0,2,0
Rickels1982-1,446_1,placebo,18,68,1982,0,2,0
Zhang2014,447,trazodone,109,192,2014,0,1,0
Zhang2014,447,placebo,67,190,2014,0,1,0
Cunningham1994 (VEN 600A-302 FDA),454,venlafaxine,47,76,1994,1,2,0
Cunningham1994 (VEN 600A-302 FDA),454,placebo,41,76,1994,1,2,0
Cunningham1994 (VEN 600A-302 FDA)-1,454_1,trazodone,43,77,1994,1,2,0
Cunningham1994 (VEN 600A-302 FDA)-1,454_1,placebo,41,76,1994,1,2,0
VEN 600A-303 (FDA),455,venlafaxine,29,83,1993,1,2,1
VEN 600A-303 (FDA),455,placebo,31,82,1993,1,2,1
VEN 600A-313 (FDA),456,venlafaxine,64,158,1993,1,2,1
VEN 600A-313 (FDA),456,placebo,26,79,1993,1,2,1
VEN XR 367 (FDA),457,venlafaxine,89,165,1993,1,2,1
VEN XR 367 (FDA),457,placebo,40,83,1993,1,2,1
VEN XR 367 (FDA)-1,457_1,paroxetine,35,81,1993,1,2,1
VEN XR 367 (FDA)-1,457_1,placebo,40,83,1993,1,2,1
Schweizer1994 (VEN 600A-301 FDA),463,venlafaxine,49,76,1994,1,2,0
Schweizer1994 (VEN 600A-301 FDA),463,placebo,37,78,1994,1,2,0
Guelfi1995 (VEN 600A-206 FDA),464,venlafaxine,24,46,1995,1,2,0
Guelfi1995 (VEN 600A-206 FDA),464,placebo,13,47,1995,1,2,0
Lecrubier1997,466,venlafaxine,50,78,1997,0,2,0
Lecrubier1997,466,placebo,38,76,1997,0,2,0
Cunningham1997 (VEN XR 208 - FDA),467,venlafaxine,104,193,1997,1,2,0
Cunningham1997 (VEN XR 208 - FDA),467,placebo,36,100,1997,1,2,0
Thase1997 (VEN XR 209 FDA),468,venlafaxine,53,95,1997,1,2,0
Thase1997 (VEN XR 209 FDA),468,placebo,30,102,1997,1,2,0
Khan1998,474,venlafaxine,139,258,1998,0,2,0
Khan1998,474,placebo,32,95,1998,0,2,0
Rudolph1998 (VEN 600A-203 (FDA),476,venlafaxine,115,266,1998,1,1,0
Rudolph1998 (VEN 600A-203 (FDA),476,placebo,27,92,1998,1,1,0
Rudolph1999,478,fluoxetine,52,103,1999,0,1,0
Rudolph1999,478,placebo,41,98,1999,0,1,0
Rudolph1999-1,478_1,venlafaxine,54,100,1999,0,1,0
Rudolph1999-1,478_1,placebo,41,98,1999,0,1,0
Silverstone1999,479,fluoxetine,67,121,1999,0,2,0
Silverstone1999,479,placebo,48,119,1999,0,2,0
Silverstone1999-1,479_1,venlafaxine,73,128,1999,0,2,0
Silverstone1999-1,479_1,placebo,48,119,1999,0,2,0
Schatzberg2006a,486,fluoxetine,37,100,2006,0,2,0
Schatzberg2006a,486,placebo,40,96,2006,0,2,0
Schatzberg2006a-1,486_1,venlafaxine,41,104,2006,0,2,0
Schatzberg2006a-1,486_1,placebo,40,96,2006,0,2,0
Nemeroff2007,487,fluoxetine,45,104,2007,0,2,0
Nemeroff2007,487,placebo,37,102,2007,0,2,0
Nemeroff2007-1,487_1,venlafaxine,51,102,2007,0,2,0
Nemeroff2007-1,487_1,placebo,37,102,2007,0,2,0
Sheehan2009a,489,fluoxetine,35,99,2009,0,1,0
Sheehan2009a,489,placebo,35,95,2009,0,1,0
Sheehan2009a-1,489_1,venlafaxine,47,95,2009,0,1,0
Sheehan2009a-1,489_1,placebo,35,95,2009,0,1,0
"Learned2012a Study1 (EUCTR2005-003401-87, SND103285, NCT00448058)",494,venlafaxine,85,134,2008,1,2,0
"Learned2012a Study1 (EUCTR2005-003401-87, SND103285, NCT00448058)",494,placebo,67,126,2008,1,2,0
Rickels2009 (GNSC-04-DP-02 FDA) (NCT00285376),498,vilazodone,88,205,2007,0,2,0
Rickels2009 (GNSC-04-DP-02 FDA) (NCT00285376),498,placebo,65,205,2007,0,2,0
Khan2011 (CLDA-07-DP-02 FDA) (NCT00683592),499,vilazodone,102,240,2009,1,1,0
Khan2011 (CLDA-07-DP-02 FDA) (NCT00683592),499,placebo,76,241,2009,1,1,0
FDA 244 (EMD 68 843-009),500,fluoxetine,30,89,1987,1,2,1
FDA 244 (EMD 68 843-009),500,placebo,35,95,1987,1,2,1
FDA 245 (EMD 68 843-010),501,fluoxetine,43,92,2011,1,2,1
FDA 245 (EMD 68 843-010),501,placebo,42,99,2011,1,2,1
FDA 246 (SB 659746-003),502,vilazodone,56,123,2011,1,2,1
FDA 246 (SB 659746-003),502,placebo,54,129,2011,1,2,1
FDA 246 (SB 659746-003)-1,502_1,citalopram,53,117,2011,1,2,1
FDA 246 (SB 659746-003)-1,502_1,placebo,54,129,2011,1,2,1
FDA 248 (SB 659746-002),504,vilazodone,63,132,2011,1,2,1
FDA 248 (SB 659746-002),504,placebo,62,128,2011,1,2,1
Croft2014 (NCT01473394),505,vilazodone,146,260,2013,0,1,0
Croft2014 (NCT01473394),505,placebo,91,258,2013,0,1,0
Mathews2015 (NCT01473381),506,vilazodone,319,583,2013,1,1,0
Mathews2015 (NCT01473381),506,placebo,125,290,2013,1,1,0
Mathews2015 (NCT01473381)-1,506_1,citalopram,151,289,2013,1,1,0
Mathews2015 (NCT01473381)-1,506_1,placebo,125,290,2013,1,1,0
"Alvarez2012 (11492A, NCT00839423)",508,placebo,42,105,2007,1,2,0
"Alvarez2012 (11492A, NCT00839423)",508,vortioxetine,147,210,2007,1,2,0
"Alvarez2012 (11492A, NCT00839423)-1",508-1,placebo,42,105,2007,1,2,0
"Alvarez2012 (11492A, NCT00839423)-1",508-1,venlafaxine,81,114,2007,1,2,0
"Jain2013 (303, NCT00672958)",509,placebo,132,300,2008,1,1,0
"Jain2013 (303, NCT00672958)",509,vortioxetine,135,300,2008,1,1,0
"Mahableshwarkar2013 (304, NCT00672620)",510,placebo,48,153,2008,1,1,0
"Mahableshwarkar2013 (304, NCT00672620)",510,vortioxetine,58,153,2008,1,1,0
"Mahableshwarkar2013 (304, NCT00672620)-1",510_1,placebo,48,153,2008,1,1,0
"Mahableshwarkar2013 (304, NCT00672620)-1",510_1,duloxetine,76,152,2008,1,1,0
"Baldwin2012 (11984A, NCT00635219)",511,placebo,68,152,2009,1,1,0
"Baldwin2012 (11984A, NCT00635219)",511,vortioxetine,174,312,2009,1,1,0
"Baldwin2012 (11984A, NCT00635219)-1",511_1,placebo,68,152,2009,1,1,0
"Baldwin2012 (11984A, NCT00635219)-1",511_1,duloxetine,85,157,2009,1,1,0
"Henigsberg2012 (305, NCT00735709)",512,placebo,32,140,2009,1,1,0
"Henigsberg2012 (305, NCT00735709)",512,vortioxetine,132,280,2009,1,1,0
"Katona2012 (12541A, NCT00811252)",513,placebo,51,145,2010,1,1,0
"Katona2012 (12541A, NCT00811252)",513,vortioxetine,82,156,2010,1,1,0
"Katona2012 (12541A, NCT00811252)-1",513_1,placebo,51,145,2010,1,1,0
"Katona2012 (12541A, NCT00811252)-1",513_1,duloxetine,93,151,2010,1,1,0
"Boulenger2014 (13267A, NCT01140906)",514,placebo,51,158,2011,1,2,0
"Boulenger2014 (13267A, NCT01140906)",514,vortioxetine,178,303,2011,1,2,0
"Boulenger2014 (13267A, NCT01140906)-1",514_1,placebo,51,158,2011,1,2,0
"Boulenger2014 (13267A, NCT01140906)-1",514_1,duloxetine,108,147,2011,1,2,0
"Jacobsen2015 (316, NCT01163266)",515,placebo,44,157,2012,1,1,0
"Jacobsen2015 (316, NCT01163266)",515,vortioxetine,110,305,2012,1,1,0
"Mahableshwarkar2015a (315, NCT01153009)",516,placebo,60,161,2012,1,1,0
"Mahableshwarkar2015a (315, NCT01153009)",516,vortioxetine,129,301,2012,1,1,0
"Mahableshwarkar2015a (315, NCT01153009)-1",516_1,placebo,60,161,2012,1,1,0
"Mahableshwarkar2015a (315, NCT01153009)-1",516_1,duloxetine,80,152,2012,1,1,0
"Mahableshwarkar2015b (317, NCT01179516)",517,placebo,49,160,2012,1,1,0
"Mahableshwarkar2015b (317, NCT01179516)",517,vortioxetine,107,309,2012,1,1,0
"NCT01355081(japicCTI-111492, U1111-1120-9277)",518,vortioxetine,117,242,2012,1,1,1
"NCT01355081(japicCTI-111492, U1111-1120-9277)",518,placebo,49,124,2012,1,1,1
"NCT01255787 (EUCTR2010-022257-41, Lu AA21004/CCT-002, U1111-1117-6595, JapicCTI-101344, CTRI/2011/08/001963)",519,placebo,59,152,2012,1,1,1
"NCT01255787 (EUCTR2010-022257-41, Lu AA21004/CCT-002, U1111-1117-6595, JapicCTI-101344, CTRI/2011/08/001963)",519,vortioxetine,226,448,2012,1,1,1
McIntyre2014 (NCT01422213),520,placebo,57,198,2013,1,1,0
McIntyre2014 (NCT01422213),520,vortioxetine,212,404,2013,1,1,0
Mahableshwarkar2015c (NCT01564862),522,vortioxetine,89,198,2014,1,1,0
Mahableshwarkar2015c (NCT01564862),522,placebo,69,194,2014,1,1,0
Mahableshwarkar2015c (NCT01564862)-1,522_1,duloxetine,102,210,2014,1,1,0
Mahableshwarkar2015c (NCT01564862)-1,522_1,placebo,69,194,2014,1,1,0
